Update on the management of venous thromboembolism

  • Cleve Clin J Med. 2017 Dec;84(12 Suppl 3):39-46. doi: 10.3949/ccjm.84.s3.04.
John R Bartholomew  1
Affiliations
  • 1. Section Head, Department of Vascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Cleveland, OH, USA. [email protected].
Abstract

Venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism, is a common Cardiovascular Disease associated with significant morbidity ranging from painful leg swelling, chest Pain, shortness of breath, and even death. Long-term complications include recurrent VTE, postpulmonary embolism syndrome, chronic thromboembolic Pulmonary Hypertension, and postthrombotic syndrome (PTS). Management of VTE requires immediate anticoagulation therapy based on a risk assessment for bleeding. Direct oral anticoagulants (DOACs) have become an important option for patients as reflected in the most recent American College of Chest Physician treatment guidelines.